Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Feb 17, 2006

Sanofi-aventis received from the FDA an approvable letter for rimonabant for weight management and a non approvable letter for smoking cessation
Feb 14, 2006

The Journal of the American Medical Association publishes the RIO-North America study

Study Shows Rimonabant Maintains Improvements in Multiple Cardiometabolic Risk Factors for Up to Two Years
Feb 6, 2006

Sanofi Pasteur Delivers More H5N1 Vaccine for U.S. Government Pandemic Initiatives

New investigational doses include formulation with an adjuvant; Additional stockpile vaccine prepared
Feb 1, 2006

Sanofi Pasteur Experiences Unprecedented U.S. Demand for Influenza Vaccine for 2006-2007 Influenza Season
Jan 30, 2006

Dynamic growth in 2005 full-year consolidated net sales: up 9.3% on a comparable basis

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.